Oxygen-Carrying Capacity of Perfluorohexyloctane, a Novel Eye Drop for Dry Eye Disease
ABSTRACT: Objective: One-hundred percent perfluorohexyloctane (PFHO) is a water-free, preservative-free eye drop approved by the Food and Drug Administration in the United States for the treatment of dry eye disease. PFHO has shown relief of dry eye signs and symptoms in clinical trials and has pote...
Saved in:
Main Authors: | Neal Stolowich, Ph.D (Author), Jason Vittitow, Ph.D (Author), Robert Kissling, M.D (Author), Douglas Borchman, Ph.D (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
In Vitro Inhibition of Evaporation with Perfluorohexyloctane, an Eye Drop for Dry Eye Disease
by: Jason Vittitow, Ph.D, et al.
Published: (2023) -
Efficacy and Safety of Miebo® (Perfluorohexyloctane Ophthalmic Solution) in Treating Dry Eye Disease - a narrative review
by: Patrycja Nowoświat, et al.
Published: (2024) -
Development of Lutein-Containing Eye Drops for the Treatment of Dry Eye Syndrome
by: Yi-Zhou Chen, et al.
Published: (2021) -
Prevalence and Risk Factors Associated with Symptomatic Dry Eye in Nurses in Palestine During the COVID-19 Pandemic
by: Riyad Allayed MSN, et al.
Published: (2022) -
Biopolymers in Mucoadhesive Eye Drops for Treatment of Dry Eye and Allergic Conditions: Application and Perspectives
by: Anđelka Račić, et al.
Published: (2023)